Why Changes are needed to Current Preformulation and Formulation Practices

Hosted By: Andrea Charles
Rate this Podcast: 
Average: 4 (3 votes)
To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

About this Podcast...

As part of the Pharma Leaders Today Series Dr. Keith Horspool, Vice President, Pharmaceutical Development US, Boehringer Ingelheim, speaks to Andrea Charles from Pharma IQ, about why changes are needed to current preformulation and formulation practices, strategies to reduce time spent in R&D and importance of the role of co-crystals in formulation design and product development.

Horspool also shares his top 3 tips for evaluating the potential of new drug delivery technologies.

  Have Your Say
Rate this feature and give us your feedback in the comments section below


Crowne Plaza Zurich, Zurich, Switzerland
June 17 - 19, 2018